コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n vitro stability of leukocytes labeled with 99mTc-exametazime.
2 abeled with the nonstabilized preparation of 99mTc-exametazime.
3 count of leukocytes labeled with stabilized 99mTc-exametazime.
4 higher LE associated with fresher stabilized 99mTc-exametazime.
5 eukocyte labeling with a more stable form of 99mTc-exametazime.
6 at reported with the standard preparation of 99mTc-exametazime.
7 cost-effective preparation of the stabilized 99mTc-exametazime and an extended window for clinical us
8 similar to in vitro results with stabilized 99mTc-exametazime and better than previously reported in
9 blue appearance of the mixture of stabilized 99mTc-exametazime and blood components, which makes it i
10 We concluded that with a small volume of 99mTc-exametazime and double dilution steps with 12.6% A
11 -, or 6-hr postreconstitution) of stabilized 99mTc-exametazime (approximately 925 MBq, approximately
12 s: (a) leukocytes labeled with nonstabilized 99mTc-exametazime, (b) leukocytes labeled with stabilize
13 steps with 12.6% ACD/NS solution, stabilized 99mTc-exametazime can be used effectively for leukocyte
14 zime, (b) leukocytes labeled with stabilized 99mTc-exametazime containing 250 microg methylene blue,
15 , and (c) leukocytes labeled with stabilized 99mTc-exametazime containing 500 microg methylene blue.
17 e buffer mixture), the in vitro stability of 99mTc-exametazime has been increased to 4-6 hr postrecon
21 Ten volunteers were injected with stabilized 99mTc-exametazime-labeled autologous leukocytes to study
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。